ASCOR® (Ascorbic Acid Injection, USP) — Product Availability Update
Updated: October 26, 2026
McGuff Pharmaceuticals, Inc. is pleased to announce that standard distribution of ASCOR® (Ascorbic Acid Injection, USP) has resumed, and the temporary filtration program has ended.
ASCOR® (Ascorbic Acid Injection, USP) is available to order through McGuff Company, Inc. We appreciate the patience and continued support of our customers and healthcare providers throughout the temporary distribution changes.
ASCOR® (Ascorbic Acid Injection, USP) Availability and Ordering
ASCOR® (Ascorbic Acid Injection, USP), 500 mg/mL, 50 mL vial, is currently available for purchase through McGuff Company, Inc.
Customers can view product information and place orders directly through our website.
View ASCOR Product & Order Online
Shipping and Order Fulfillment
ASCOR® (Ascorbic Acid Injection, USP) orders are processed through our standard distribution channels, with standard shipping taking a maximum of three consecutive business days.
Orders shipped to the Western United States may be sent via UPS Ground, while orders to other regions are shipped using UPS 3-Day service. Orders are not shipped over weekends.
Expedited shipping is available for an additional charge.
For questions regarding your order or estimated shipping date, please contact our Customer Service team.
Current Product Instructions
With standard distribution resumed, the temporary filtration program has concluded.
Customers should follow the labeling, prescribing information, and any lot-specific instructions applicable to the ASCOR® (Ascorbic Acid Injection, USP) product they receive.
Important Information Regarding Previously Distributed Lots
On November 13, 2025, McGuff Pharmaceuticals issued FDA-hosted communications outlining additional administration instructions for certain ASCOR® (Ascorbic Acid Injection, USP) lots distributed during the earlier program.
These communications remain important for healthcare providers who may still possess affected inventory. The instructions differ depending on the specific lot and whether the product was supplied with a filtered extension set.
Healthcare providers should review the applicable instructions before preparing or administering previously distributed ASCOR® (Ascorbic Acid Injection, USP) inventory.
- FDA Communication – Important Drug Administration Information (November 13, 2025)
- FDA Communication – Prescribing Change for Specified Lots (November 13, 2025)
Important: The conclusion of the temporary filtration program does not supersede instructions applicable to previously distributed affected lots.
Questions or Order Assistance?
Our Customer Service team is available to assist with ASCOR® (Ascorbic Acid Injection, USP) product availability, ordering, shipping inquiries, and questions regarding previously distributed inventory.
McGuff Company, Inc.
Customer Service: 1 (800) 854-7220
Email: answers@mcguff.com
For medical information or to report an adverse event, please contact McGuff Pharmaceuticals, Inc. at 1 (800) 603-4795.
We sincerely appreciate your continued trust in McGuff and remain committed to providing healthcare professionals with reliable access to quality pharmaceutical products.